Table 1 List of probiotics with potential activity against H. pylori infection by in vitro and in vivo studies
From: Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections
Probiotic name | Potential activity | Human/animal/in-vitro examination | Country | Ref |
|---|---|---|---|---|
L. salivarius WB1004 | Inhibition of colonization, lactic acid | BALB/c mice | Japan | [62] |
L. acidophilus (johnsonii) La1 | Inhibition of colonization, lactic acid, H2O2, bacteriocins | Human | Switzerland | [63] |
L. johnsonii La1 | Inhibition of colonization, lactic acid, H2O2, bacteriocins | Human | Switzerland | [64] |
L. acidophilus CRL 639 | Autolysins, lactic acid | In-vitro | Sweden | [65] |
L. gasseri OLL 2716 | Anti-inflammatory activity, lactic acid | Human | Japan | [66] |
L. reuteri | Anti-inflammatory activity (inhibition of IL-8 synthesis), lactic acid | In-vitro | Canada | [67] |
L. casei Shirota | Biocine, lactic acid, Inhibition of colonization | Human | Netherlands | [68] |
L. casei Shirota | Biocine, lactic acid, Inhibition of colonization | C57BL/6 mice | Greece | [69] |
L. brevis | Arginine deiminase activity, inhibition of colonization | Human | Italy | [70] |
L. rhamnosus R0011 and L. acidophilus R0052 | Inhibition of colonization, lactic acid | C57BL/6 mice | Canada | [71] |
L. salivarius | Lactic acid, bacteriocin | In-vitro | Ireland | [72] |
L. bulgaricus BB18 and Enterococcus faecium MH3 | Lactic acid, bulgaricin BB18, enterocin MH3 | In-vitro | Bulgaria | [73] |
L. brevis BK11 and E. faecalis BK61 | Lactic acid, bacteriocin | In-vitro | Korea | [74] |
L. lactis A164 and L. lactis BH5 | Lactic acid, lacticin A164, lacticin BH5 | In-vitro | Korea | [75] |
Bacillus clausii | inhibition of colonization (bacterial cell and spores) | Human | Italy | [76] |
B. subtilis | Amicoumacin A | In-vitro | France | [77] |
Lactobacilli and Bifidobacteria | Lactic acid | Human | Germany | [78] |
Weissella confusa PL9001 | Bacteriocin, inhibition of colonization | In-vitro | Korea | [79] |
E. faecium GM-1 | Lactic acid, bacteriocin? | In-vitro | South Korea | [80] |
E. faecium TM39 | Lactic acid, bacteriocin | In-vitro | Taiwan | [81] |
Saccharomyces boulardii | Anti-inflammatory activity | Human | Romania | [82] |
L. reuteri ATCC 55730 | Reuterin | Human | Italy | [83] |
L. rhamnosus JB3 | Antagonist of AI‐2 | In-vitro | Taiwan | [84] |